The chemokine receptors CCR2 and CCR5 are major chemotactic regulators of tumor-promoting macrophages at the tumor site, and blockade of these receptors impair tumor progression in experimental animal models10–13,16,17,38,39. The gene discussed is CCR2; the disease is neoplasm.